Goldman Sachs Group »

Adagio Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $213k 54k 3.94
2023-09-30 $39k 23k 1.70
2023-06-30 $46k 44k 1.05
2023-03-31 $99k 82k 1.20
2022-12-31 $97k 65k 1.50
2022-06-30 $1.4M 413k 3.28
2022-03-31 $175k 38k 4.55
2021-12-31 $167k 23k 7.27